Tenofovir-associated proteinuria
| Data(s) |
28/01/2013
|
|---|---|
| Resumo |
Proteinuria was observed in 27% of 153 patients taking tenofovir for more than 1 year. Concomitant protease inhibitor therapy and cumulative tenofovir exposure were independently associated with proteinuria in this cohort. Proteinuria was reversible in 11 of 12 patients who ceased tenofovir because of proteinuria without altering other medications. Clinicians should be aware that tenofovir can cause reversible proteinuria in patients with HIV. |
| Formato |
application/pdf |
| Identificador | |
| Publicador |
Lippincott Williams & Wilkins, Inc. |
| Relação |
http://eprints.qut.edu.au/58522/1/TAP_LTA_post_review_%28for_e-prints%29.pdf DOI:10.1097/QAD.0b013e32835883bf Kelly, Mark D., Gibson, Abby, Bartlett, Harry, Rowling, Diane, & Patten, John (2013) Tenofovir-associated proteinuria. AIDS, 27(3), pp. 479-481. |
| Direitos |
© 2013 Lippincott Williams & Wilkins, Inc. This is a non-final version of an article published in final form in AIDS: 28 January 2013 - Volume 27 - Issue 3 - p 479–481 doi: 10.1097/QAD.0b013e32835883bf |
| Fonte |
Institute for Future Environments; School of Mathematical Sciences; Science & Engineering Faculty |
| Palavras-Chave | #111700 PUBLIC HEALTH AND HEALTH SERVICES #proteinuria #chronic kidney disease #tenofovir #HIV |
| Tipo |
Journal Article |
